Torrent Pharmaceuticals Ltd.

TORNTPHARM

Market Cap
₹88,140 Cr.
P/E
59.00

Torrent Pharmaceuticals Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

12 Yes

Positive for this company

1 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
20.09%
3yr Average
18.2%
5yr Average
17.01%
Net Profit Margin
Latest
12.94%
3yr Average
12.57%
5yr Average
11.26%
ROCE
Latest
24.17%
3yr Average
23.21%
5yr Average
21.27%
Debt to Equity
Latest
0.85
3yr Average
0.79
5yr Average
0.97
Market Share
3.16% (as of Jul 22)
Anti - Diabetes - Market Share
0.84% (as of Jul 22)
Anti-Infectives - Market Share
0.74% (as of Nov 21)
Anti-Malarial - Market Share
0.27% (as of Nov 21)
Antineo Plastic - Market Share
0.26% (as of Nov 21)
Blood Related - Market Share
7.22% (as of Jul 22)
Cardiovascular - Market Share
1.22% (as of Nov 21)
Dermatology - Market Share
0.01% (as of May 21)
Endocrinology - Market Share
4.93% (as of Jul 22)
Gastro-Intestinal - Market Share
1.50% (as of Nov 21)
Gynecology - Market Share
20% (as of Mar 19)
Losartan & Lamtrigine - Market Share in Brazil
locked Source
7.53% (as of Nov 21)
Neurological - Market Share
0.01% (as of Mar 18)
Ophthalmology - Market Share
3.05% (as of Nov 21)
Pain - Market Share
3.40% (as of Dec 22)
Pharmaceutical Sector - Market Share
0.19% (as of Nov 21)
Respiratory - Market Share
0% (as of Jul 22)
Sex Stimulants - Market Share
30% (as of Mar 19)
Shelcal - Market Share
locked Source
34.62% (as of May 19)
Stomatological - Market Share
0.40% (as of Nov 21)
Urology - Market Share
4.78% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Break-Up

locked
Source
|
Latest
|
locked
Historic

Acute vs Chronic

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Domestic Sales Growth - YoY (%)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Brands
    Losar
    Shelcal
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Torrent Pharmaceuticals Ltd.
    View the discussion on ValuePickr
    Interview With Dilip Sanghvi, Managing Director - Sun Pharmaceutical Samir Mehta, Chairman - Torrent Pharma - Flame University
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline